All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2026-P-3840
Requests that the FDA to allow us to add the 100 mL bottle in ANDA 214382, according to the FDA guidance document "Determining Whether to Submit an ANDA or a 505(b) (2) Application", effective May 2019.
Documents
7
Comments
0
Key Dates
Comment Period OpensApr 10, 2026
Documents
| Type | Title | Status |
|---|---|---|
Supporting Material |
Keywords
CDER
Suitability Petition
Emprise Pharma LLC
Shandong New Time Pharmaceutical Co Ltd
to allow us to
add the 100 mL bottle in ANDA 214382
according to the FDA guidance document
Determining Whether to Submit an ANDA
Data from Regulations.gov